Patent

Method of detecting HEV infection

The United States of America as represented by the Department of Health and Human Services and Genelabs Technologies, Inc.,

US 6,379,891 B1GrantedGranted Apr 30, 2002Filed Apr 19, 2000

Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic method for detecting infection by the enterically transmitted agent. Specific epitopes have been identified that are reactive with sera of individual infected with different strains of HEV. Also disclosed are DNA probes derived from a cloned sequence of the viral agent. These probes are useful for identifying and sequencing the entire viral agent and for assaying the presence of the viral agent in an infected sample, by using probe-specific amplification of virus-derived DNA fragments.

Claims
5
2 independent claims
Filing to grant
2.0 years
Pendency
Earliest priority
1988
Jun 17, 1988

1ClaimsFirst of 5

  1. 1

    A method for detecting the presence of an enterically transmitted nonA/nonB hepatitis viral agent in a biological sample, comprising preparing a mixture of duplex DNA fragments derived from the sample, denaturing the duplex fragments, adding to the denatured DNA fragments, a pair of single-strand primers derived from nonhomologous regions of opposite strands of a DNA duplex fragment derived from an enterically transmitted viral hepatitis agent whose genome contains a region which is homologous…

2Description

Introduction

1. Field of Invention

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API

See something wrong or missing on this page?